Overview

Update
Total Equity Funding
$49.7M in 5 Rounds from 2 Investors
Most Recent Funding
$25M Private Equity on July 30, 2014
Headquarters:
Cambridge, MA
Description:
Gen9 provides gene synthesis technology that enables the high-throughput, automated production of DNA constructs.
Founders:
, ,
Categories:
Genetic Engineering, Genetic Testing, Biotechnology
Website:
http://www.gen9bio.com
Social:

Company Details

Update

Gen9 is building on advances in synthetic biology to power a scalable fabrication capability that will significantly increase the world’s capacity to produce DNA content. The privately held company’s next-generation gene synthesis technology allows for the high-throughput, automated production of DNA constructs at lower cost and higher accuracy than previous methods on the market. Founded by world leaders in synthetic biology, Gen9 aims to ensure the constructive application of synthetic biology in industries ranging from enzyme and chemical production to pharmaceuticals and biofuels.

Funding Rounds (6) - $50.1M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jul, 2014$25M / Private Equity0
Apr, 2013$21M / Private Equity1
May, 2012$395k / Debt Financing0
Sep, 2011$1.5M / Seed1
Feb, 2011$1.7M / Seed0
Jun, 2009$500k / Seed0

Current Team (7)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    500 Technology Square

    First Floor

    Cambridge, MA 02139

    USA

Past Team (1)

Update

Past Event Appearances (1)

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos